Corporate ActionJul 2, 2026, 05:22 PM
Lifecore Biomedical Receives Notices for All Series A Preferred Stock Redemption
AI Summary
Lifecore Biomedical, Inc. announced it received redemption notices for all 49,263 outstanding shares of its Series A Redeemable Convertible Preferred Stock between June 29 and June 30, 2026. The total redemption amount, including accrued dividends, is approximately $52.1 million, due by December 28, 2026. As of March 31, 2026, the company had $38.1 million in total liquidity, comprising $20.8 million in cash and $17.3 million in revolving credit facility availability. The company is evaluating strategic alternatives, including financing options and seeking lender consent, to facilitate the redemption.
Key Highlights
- Received redemption notices for 49,263 shares of Series A Preferred Stock.
- Redemption price is $1,000 per share plus accrued dividends.
- Accrued and unpaid dividends totaled $0.9 million as of June 30, 2026.
- Total liquidation value of Series A Preferred Stock was approximately $50.2 million.
- Total redemption amount required by December 28, 2026 is approximately $52.1 million.
- Company had $38.1 million in total liquidity as of March 31, 2026.
- Liquidity included $20.8 million in cash and $17.3 million in revolving credit facility availability.
Price Impact
More from LFCR